The story of Medvi has become the definitive “poster child” for the 2026 One-Person Company (OPC) movement. Founded by Matthew Gallagher and his brother, the startup achieved a staggering $401 million in revenue for the 2025 calendar year with just two full-time employees.
By leveraging a “lean” AI-first infrastructure, Medvi is currently tracking toward $1.8 billion in sales for 2026, positioning it as one of the most efficient companies in history by revenue-per-employee.
1. The Business Model: “GLP-1 as a Service”
Medvi’s explosive growth is driven by the global surge in demand for weight-loss medications like Ozempic, Wegovy, and Zepbound.
- The Core Product: A telehealth platform that streamlines the prescription and delivery of GLP-1 drugs.
- AI Orchestration: Instead of hiring hundreds of support staff, Gallagher invested approximately $20,000 in a custom stack of over a dozen AI agents. These agents handle:
- Patient Triage: Initial health screenings and eligibility checks.
- Insurance Navigation: Automated “Prior Authorization” filing (traditionally a massive labor bottleneck).
- Customer Support: Managing 95% of patient inquiries without human intervention.
- The “Human-in-the-Loop”: While AI manages the logistics, Medvi partners with a third-party network of licensed medical providers who perform the final clinical review and issue prescriptions.
2. Efficiency Metrics: Medvi vs. Hims & Hers
The industry is currently obsessed with the “Efficiency Gap” between Medvi and its publicly traded competitors.
| Metric | Medvi (2-Man Startup) | Hims & Hers (Public Co.) |
| Employees | 2 | ~2,400 |
| 2025 Revenue | $401 Million | ~$2.4 Billion |
| Net Profit Margin | 16.2% ($65M) | ~5.5% |
| Rev per Employee | $200.5 Million | ~$1 Million |
3. The “Vibe Coding” Origin Story
Matthew Gallagher reportedly built the initial version of Medvi in just two months using vibe coding tools like Cursor and Replit.
- The “Zero-Capital” Start: He launched the business with just $20,000 of his own savings, primarily spent on AI API credits and initial marketing.
- Viral Marketing: Medvi bypassed traditional ad agencies by using AI-generated content and performance-marketing loops that adjusted in real-time based on conversion data.
4. Valuation & “The $1.8B Track”
The New York Times recently profiled Medvi as the leading example of how AI has “collapsed the cost of scaling.”
- Current Valuation: While private, secondary market interest suggests a valuation between $1.5 billion and $2 billion based on its 2026 revenue trajectory.
- The “Reseller” Debate: Critics on Hacker News and elsewhere argue that Medvi is essentially a high-tech “reseller” of third-party clinical services. However, investors point to its 16.2% net margin—triple that of its peers—as proof that its AI-driven “middleware” is where the true value lies.
5. Why It Matters: The “Unicorn of Two”
Medvi is being cited by venture capital firms like Bessemer as proof of the “Health AI X Factor.” It proves that in 2026, the “moat” for a startup is no longer headcount or proprietary algorithms, but the ability to orchestrate autonomous agents to solve high-friction regulatory and logistical problems in real-time.
